自噬介导去毒附子汤调控滑膜成纤维细胞ATG12-IRF1-VCAM1轴干预老年膝骨关节炎的机制研究
批准号:
82104890
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
周莉
依托单位:
学科分类:
中医骨伤科学
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
周莉
中文摘要
膝骨关节炎(KOA)是好发于老年人的退行性疾病,是骨科临床难题。滑膜炎症是老年KOA的主要特征和干预途径,但现有药物疗效有限,无法满足临床需求。自噬衰退是老年KOA滑膜炎症发生和进展的重要诱因,激活自噬能有效缓解滑膜炎症及关节退变。申请人前期首次发现自噬蛋白ATG12通过互作调控IRF1转录活性,参与VCAM1介导的滑膜炎症,该分子路径可能是老年KOA滑膜炎症的关键干预靶点。KOA属中医“骨痹”,适用散寒止痛之法。经方附子汤能有效改善KOA滑膜炎症及关节退变。团队建立去毒附子汤,证明该方能激活滑膜自噬,并提出假说:自噬ATG12-IRF1-VCAM1轴是介导老年KOA滑膜炎症进展及去毒附子汤干预的关键机制。申请人拟通过动物、细胞及分子实验验证该假说,探究去毒附子汤对老年KOA自噬的调控机制,旨在完善KOA自噬相关病机和中药干预的科学内涵,为临床应用去毒附子汤防治老年KOA提供实证依据。
英文摘要
Knee osteoarthritis (KOA) is an aging related degenerative disease and unsettled topic in orthopedic clinic. Synovitis is an important characteristic as well as intervention indicator of senile KOA. However, limited efficacy of the existing drugs disappoints these clinical KOA patients. Autophagy decline is one of the main causes of synovitis in senile KOA. Autophagy restoration is considered as potential intervention of synovitis and joint degeneration. The applicant found for the first time that autophagy protein ATG12 regulated VCAM1-mediated synovitis through protein interaction with IRF1, upstream transcriptional factor of VCAM1. KOA is defined as bone bi-disease in traditional Chinese medicine (TCM), so that therapies dispersing cold and pain have been considered as targeted TCM cure for KOA. Detoxified Fuzi decoction is prepared with Fuzi produced through self-designed detoxification process. While applied in KOA rats, detoxified Fuzi decoction shows promising efficacy in relieving synovitis and joint degeneration in KOA. The applicant has also proved that detoxified Fuzi decoction could activate autophagy in synovial fibroblasts. Taken together, we hypothesize that detoxified Fuzi decoction activates autophagic ATG12-IRF1-VCAM1 axis in synovial fibroblasts to inhibit synovitis in senile KOA and related joint degeneration. Through animal, cellular and molecular studies, we aim to reveal the mechanism of detoxified Fuzi decoction in the regulation of autophagic ATG12-IRF1-VCAM1 axis. We also hope to replenish the scientific connotation of autophagy-related pathogenesis and intervention of senile KOA, and provide experimental evidences for the clinical application of detoxified Fuzi decoction in senile KOA.
膝骨关节炎(KOA)是常见的退行性骨关节病,致残率极高。中老年人是KOA易感人群。在人口老龄化日益加剧的国情下,KOA的防治已成为亟待解决的公共卫生问题。KOA发病机制复杂,现有药物尚不能满足临床需求。中药复方具有多成分、多靶点的优势,是极具潜力的KOA候选药物库。本项目以KOA滑膜炎症为切入点,围绕其自噬病机与去毒附子汤的干预机制完成了以下研究:1) 构建KOA大鼠模型,完成模型与自噬相关性评价;2)制备符合质控标准的去毒附子汤,在KOA动物模型中灌胃给药并应用小分子化合物阻断自噬,明确自噬是去毒附子汤的干预靶点,通过检测血清生物学、免疫组化及分子生物学指标进行体内机制研究;3)建立滑膜成纤维细胞体外炎症模型,分组给以含药血清干预,揭示去毒附子汤激活自噬缓解滑膜炎症的分子机制;4)通过关节腔注射靶基因敲减(AAV-shRNA)/过表达(AAV-OE)的腺相关病毒/VCAM1激活剂,验证去毒附子汤调控ATG12-IRF1-VCAM1信号轴缓解KOA滑膜炎症及关节退变的分子机制。.本项目建立了大鼠KOA模型,通过比较成年及老年大鼠对照、模型与自噬活化组在关节退变、滑膜炎症与自噬水平的差异,发现老年大鼠本底的自噬水平低于成年大鼠,但造模后自噬水平均会进一步降低,活化自噬可改善KOA症状。在滑膜成纤维细胞中应用GFP-RFP-LC3双荧光系统、Co-IP、核质分离等技术,项目组证实了去毒附子汤激活自噬促进ATG12-IRF1互作,进而调控VCAM1表达与黏附功能的作用机制。在KOA模型中应用自噬抑制剂、AAV腺相关病毒敲减ATG12/过表达IRF1及LPS持续激活VCAM1,发现抑制自噬或阻断ATG12-IRF1-VCAM1轴均能逆转去毒附子汤改善KOA滑膜炎症的药效作用。.研究结果表明,自噬衰退是伴随KOA发生的关键事件,也是KOA干预的潜在靶点,去毒附子汤可通过自噬依赖途径调控ATG12-IRF1-VCAM1轴干预KOA滑膜炎症及关节退变。本项目不仅阐明了去毒附子汤抗炎干预KOA的作用机理,为其临床应用和二次开发提供了科学依据,也为基于KOA自噬相关病机的新药开发奠定了基础。
附子汤通过m6A 甲基化激活 Jak1/STAT6 纠正
滑膜巨噬细胞异常极化的抗骨关节炎机制研
究
-
批准号:Y24H270051
-
项目类别:省市级项目
-
资助金额:0.0万元
-
批准年份:2024
-
负责人:周莉
-
依托单位:
国内基金
海外基金